Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506.

PubWeight™: 5.92‹?› | Rank: Top 1%

🔗 View Article (PMC 2975982)

Published in Surgery on July 01, 1991


N Murase1, A J Demetris, T Matsuzaki, A Yagihashi, S Todo, J Fung, T E Starzl

Author Affiliations

1: Department of Surgery, University Health Center, Pittsburgh, Pa.

Articles citing this

Cell migration, chimerism, and graft acceptance. Lancet (1992) 12.24

Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology (1993) 8.76

The many faces of multivisceral transplantation. Surg Gynecol Obstet (1991) 6.89

Intestinal transplantation in composite visceral grafts or alone. Ann Surg (1992) 4.96

Donor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantation. Immunol Today (1993) 4.29

Replacement of donor lymphoid tissue in small-bowel transplants. Lancet (1991) 3.85

Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation (1995) 3.63

Chimerism and donor-specific nonreactivity 27 to 29 years after kidney allotransplantation. Transplantation (1993) 3.13

Outcome analysis of 71 clinical intestinal transplantations. Ann Surg (1995) 2.95

Hematolymphoid cell trafficking, microchimerism, and GVH reactions after liver, bone marrow, and heart transplantation. Transplant Proc (1993) 2.81

Cadaveric small bowel and small bowel-liver transplantation in humans. Transplantation (1992) 2.75

Management of intestinal transplantation in humans. Transplant Proc (1992) 2.62

Clinical intestinal transplantation: new perspectives and immunologic considerations. J Am Coll Surg (1998) 2.31

Assessment of five-year experience with abdominal organ cluster transplantation. J Am Coll Surg (1995) 2.25

Three years clinical experience with intestinal transplantation. J Am Coll Surg (1994) 2.20

Graft-versus-host disease after brown Norway-to-Lewis and Lewis-to-Brown Norway rat intestinal transplantation under FK506. Transplantation (1993) 2.14

Prevention of graft-versus-host disease following allogeneic bone marrow transplantation in rats using FK506. Transplantation (1991) 1.95

Lymphocyte traffic and graft-versus-host disease after fully allogeneic small bowel transplantation. Transplant Proc (1991) 1.89

The saga of liver replacement, with particular reference to the reciprocal influence of liver and kidney transplantation (1955-1967). J Am Coll Surg (2002) 1.81

Transplantation tolerance, microchimerism, and the two-way paradigm. Theor Med Bioeth (1998) 1.67

Donor dendritic cells after liver and heart allotransplantation under short-term immunosuppression. Lancet (1992) 1.61

Immunomodulation for intestinal transplantation by allograft irradiation, adjunct donor bone marrow infusion, or both. Transplantation (2000) 1.53

Morphological monitoring of human small bowel allografts. Transplant Proc (1993) 1.52

Clinical intestinal transplantation: a decade of experience at a single center. Ann Surg (2001) 1.44

100 multivisceral transplants at a single center. Ann Surg (2005) 1.34

Canine total orthotopic small bowel transplantation under FK 506. Transplant Proc (1991) 1.29

Spontaneous and iatrogenically augmented leukocyte chimerism in organ transplant recipients. Transplant Proc (1994) 1.29

Current status of intestinal transplantation in children. J Pediatr Surg (1998) 1.28

Comparison of the small intestine after multivisceral transplantation with the small intestines transplanted with portal or caval drainage. Transplant Proc (1992) 1.26

Clinical small bowel or small bowel plus liver transplantation under FK 506. Transplant Proc (1991) 1.24

Intestinal and multivisceral transplantation in children. Ann Surg (2006) 1.22

Dendritic cell replacement in long-surviving liver and cardiac xenografts. Transplantation (1993) 1.10

Graft-versus-host disease after liver and small bowel transplantation in a child. Clin Transplant (1997) 1.09

Chimerism and tolerance in transplantation. Proc Natl Acad Sci U S A (2004) 1.07

The influence of donor and recipient strains in isolated small bowel transplantation in rats. Transplant Proc (1994) 1.04

Donor hematopoietic progenitor cells in nonmyeloablated rat recipients of allogeneic bone marrow and liver grafts. Transplantation (1999) 1.04

Intestinal transplantation in children under FK 506 immunosuppression. J Pediatr Surg (1993) 1.02

Acquired immunologic tolerance: with particular reference to transplantation. Immunol Res (2007) 0.97

History of clinical transplantation. World J Surg (2000) 0.91

Infusion of donor leukocytes to induce tolerance in organ allograft recipients. J Leukoc Biol (1999) 0.85

New immunosuppressive drugs: mechanistic insights and potential therapeutic advances. Immunol Rev (1993) 0.84

A new protocol for the propagation of dendritic cells from rat bone marrow using recombinant GM-CSF, and their quantification using the mAb OX-62. J Immunol Methods (1995) 0.84

The future of transplantation: with particular reference to chimerism and xenotransplantation. Transplant Proc (1997) 0.83

Recent advances in hepatic transplantation at the University of Pittsburgh. Clin Transpl (1993) 0.83

Simultaneous bone marrow and intestine transplantation promotes marrow-derived hematopoietic stem cell engraftment and chimerism. Blood (2006) 0.82

Early passenger leukocyte migration and acute immune reactions in the rat recipient spleen during liver engraftment: with particular emphasis on donor major histocompatibility complex class II+ cells. Transplantation (2002) 0.81

Histologic monitoring of human small bowel allografts with clinical correlation. Transplant Proc (1992) 0.81

Effect of rejection on electrophysiologic function of canine intestinal grafts: correlation with histopathology and Na-K-ATPase activity. J Invest Surg (1996) 0.79

Chronic rejection. A general overview of histopathology and pathophysiology with emphasis on liver, heart and intestinal allografts. Ann Transplant (1997) 0.79

Influence of graft perfusion pressure on graft viability after small bowel preservation and transplantation. Transplant Proc (1996) 0.79

Allograft and xenograft acceptance under FK-506 and other immunosuppressant treatment. Ann N Y Acad Sci (1993) 0.79

Relative contribution of direct and indirect allorecognition in developing tolerance after liver transplantation. Liver Transpl (2008) 0.78

Current status of intestinal transplantation. Adv Surg (1994) 0.78

Lymphocyte trafficking using in situ hybridization and physioanatomy of the intestinal immune system after human small bowel transplantation. Transplant Proc (1992) 0.78

Intestinal transplantation. Annu Rev Med (1994) 0.78

Documentation in bone-marrow-augmented organ recipients of the presence of dendritic cell progenitors of donor origin. Transplant Proc (1997) 0.77

Immunity and tolerance are related, and governed by antigen migration and localization. Transplant Proc (1999) 0.77

Pathology of Chronic Rejection: An Overview of Common Findings and Observations About Pathogenic Mechanisms and Possible Prevention. Graft (Georget Tex) (1998) 0.76

The birth of clinical organ transplantation. J Am Coll Surg (2001) 0.76

Matching and the black recipient. Transplant Proc (1993) 0.75

Influence of donor-recipient strain combinations on immunologic responses after allogeneic rat small bowel transplantation. Transplant Proc (1994) 0.75

Regulation of immune reactivity and tolerance by antigen migration and localization: with particular reference to allo- and xenotransplantation. Transplant Proc (1999) 0.75

Total orthotopic small bowel transplantation in swine under FK 506. Transplant Proc (1994) 0.75

Successful combined liver and small intestine transplantation for short-gut syndrome and liver failure. West J Med (1993) 0.75

The basis of allograft acceptance. Forum (Genova) (1997) 0.75

Current perspectives of transplantation immunology via the intestine. Transplant Proc (1996) 0.75

The Role of Cell Migration and Chimerism in Organ Transplant Acceptance and Tolerance Induction. Transplant Sci (1993) 0.75

In situ proliferating status of mononuclear cells in rat small bowel grafts. Int J Exp Pathol (1995) 0.75

Intestinal and multivisceral transplantation. Einstein (Sao Paulo) (2015) 0.75

Length of transplanted small bowel required for adequate weight gain in rats. Pediatr Surg Int (1997) 0.75

Articles cited by this

Induction of immunological tolerance by porcine liver allografts. Nature (1969) 5.89

Demonstration and characterization of Ia-positive dendritic cells in the interstitial connective tissues of rat heart and other tissues, but not brain. J Exp Med (1981) 5.00

Successful small-bowel/liver transplantation. Lancet (1990) 4.85

Homotransplantation of multiple visceral organs. Am J Surg (1962) 4.28

Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporine. Transplant Proc (1987) 4.21

Effects of insulin, glucagon, and insuling/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs. Lancet (1976) 3.74

Transplantation of multiple abdominal viscera. JAMA (1989) 3.59

Rejection of multivisceral allografts in rats: a sequential analysis with comparison to isolated orthotopic small-bowel and liver grafts. Surgery (1990) 3.18

The use of FK-506 for small intestine allotransplantation. Inhibition of acute rejection and prevention of fatal graft-versus-host disease. Transplantation (1990) 2.79

Soluble HLA antigens in the circulation of liver graft recipients. Transplantation (1989) 2.48

Toxicology of FK-506 in the Lewis rat. Transplant Proc (1987) 2.37

The Eck fistula in animals and humans. Curr Probl Surg (1983) 2.35

FK506 suppression of heart and liver allograft rejection. II: The induction of graft acceptance in rats. Transplantation (1990) 2.13

Splanchnic transplantation. An approach to the infant dependent on parenteral nutrition who develops irreversible liver disease. JAMA (1989) 2.10

The influence of portal blood upon lipid metabolism in normal and diabetic dogs and baboons. Surg Gynecol Obstet (1975) 1.91

Early events in liver allograft rejection. Delineation of sites of simultaneous intragraft and recipient lymphoid tissue sensitization. Am J Pathol (1991) 1.78

Induction of DR/IA antigens in human liver allografts. An immunocytochemical and clinicopathologic analysis of twenty failed grafts. Transplantation (1985) 1.75

Successful orthotopic small bowel transplantation with short-term FK 506 immunosuppressive therapy. Transplant Proc (1990) 1.71

Expression of major histocompatibility complex antigens and replacement of donor cells by recipient ones in human liver grafts. Transplantation (1987) 1.65

Renal homotransplantation with venous outflow or infusion of antigen into the portal vein of dogs or pigs. Transplantation at portal site. Transplantation (1977) 1.54

Portal versus caval venous drainage of small bowel allografts: technical and metabolic consequences. Surgery (1986) 1.50

Maltose absorption as an indicator of small-intestinal allograft rejection. J Surg Res (1984) 1.50

Immunologic and metabolic effects of caval versus portal venous drainage in small-bowel transplantation. Surgery (1988) 1.50

Multivisceral intestinal transplantation: surgical pathology. Pediatr Pathol (1989) 1.45

Expression of HLA-DR antigens on bileduct cells of rejected liver transplant. Lancet (1984) 1.31

Origin of lymph node-derived lymphocytes in human hepatic allografts. Clin Transpl (1989) 1.24

Prolongation of intestinal allograft survival without immunosuppressive drug therapy. Transplantation of small bowel allografts. J Surg Res (1983) 1.20

Nutritional and metabolic aspects of total small bowel transplantation in inbred rats. Transplant Proc (1987) 1.19

A comparison of portal and systemic venous drainage in porcine renal allografts. Br J Surg (1972) 1.01

Functional characteristics of lymphocytes propagated from a human multivisceral allograft. Clin Transplant (1990) 0.94

Articles by these authors

Evolution of liver transplantation. Hepatology (1982) 19.54

FK 506 for liver, kidney, and pancreas transplantation. Lancet (1989) 13.70

Cell migration, chimerism, and graft acceptance. Lancet (1992) 12.24

A flexible procedure for multiple cadaveric organ procurement. Surg Gynecol Obstet (1984) 10.33

The Banff 97 working classification of renal allograft pathology. Kidney Int (1999) 9.02

Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology (1993) 8.76

Orthotopic liver transplantation in ninety-three patients. Surg Gynecol Obstet (1976) 8.11

Kidney transplantation under FK 506. JAMA (1990) 7.45

The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet (1980) 7.40

The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation. Surg Gynecol Obstet (1967) 7.24

Fifteen years of clinical liver transplantation. Gastroenterology (1979) 7.19

Venous bypass in clinical liver transplantation. Ann Surg (1984) 7.04

Liver transplantation with use of cyclosporin a and prednisone. N Engl J Med (1981) 6.95

The many faces of multivisceral transplantation. Surg Gynecol Obstet (1991) 6.89

Orthotopic homotransplantation of the human liver. Ann Surg (1968) 6.64

Vascular homografts from cadaveric organ donors. Surg Gynecol Obstet (1979) 6.23

A ras-related gene with transformation suppressor activity. Cell (1989) 5.81

Abdominal organ cluster transplantation for the treatment of upper abdominal malignancies. Ann Surg (1989) 5.78

Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) (1988) 5.77

Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet (1984) 5.74

Refinements in the surgical technique of liver transplantation. Semin Liver Dis (1985) 5.70

Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart, and pancreas islet transplantation. Lancet (1994) 5.54

Progress in and deterrents to orthotopic liver transplantation, with special reference to survival, resistance to hyperacute rejection, and biliary duct reconstruction. Transplant Proc (1974) 5.53

Extended survival in 3 cases of orthotopic homotransplantation of the human liver. Surgery (1968) 5.44

Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant (2007) 5.39

Cyclophosphamide and whole organ transplantation in human beings. Surg Gynecol Obstet (1971) 5.24

Alternative methods of arterialization of the hepatic graft. Surg Gynecol Obstet (1984) 5.16

Immunosuppression of canine, monkey, and baboon allografts by FK 506: with special reference to synergism with other drugs and to tolerance induction. Surgery (1988) 5.03

Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg (1990) 5.01

Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications. Transplant Proc (1990) 4.90

Liver transplantation (1). N Engl J Med (1989) 4.53

Pancreaticoduodenal transplantation in humans. Surg Gynecol Obstet (1984) 4.49

Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology (1994) 4.32

A simplified technique for revascularization of homografts of the liver with a variant right hepatic artery from the superior mesenteric artery. Surg Gynecol Obstet (1985) 4.29

Donor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantation. Immunol Today (1993) 4.29

Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporine. Transplant Proc (1987) 4.21

Pancreatic islet transplantation after upper abdominal exenteration and liver replacement. Lancet (1990) 4.18

Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery (1994) 4.16

Orthotopic liver transplantation with preservation of the inferior vena cava. Ann Surg (1989) 4.12

Malignant lymphomas in transplantation patients. Transplant Proc (1969) 4.12

Role of liver transplantation in cancer therapy. Ann Surg (1985) 4.08

Biliary complications after liver transplantation: with special reference to the biliary cast syndrome and techniques of secondary duct repair. Surgery (1977) 4.08

Shwartzman reaction after human renal homotransplantation. N Engl J Med (1968) 4.05

Baboon-to-human liver transplantation. Lancet (1993) 4.01

Extended preservation of human liver grafts with UW solution. JAMA (1989) 3.99

Canine and human liver preservation for 6 to 18 hr by cold infusion. Transplantation (1977) 3.99

Clinical presentation of hepatic artery thrombosis after liver transplantation in the cyclosporine era. Transplantation (1985) 3.91

The preparation and testing of horse antidog and antihuman antilymphoid plasma or serum and its protein fractions. Surg Gynecol Obstet (1967) 3.86

Replacement of donor lymphoid tissue in small-bowel transplants. Lancet (1991) 3.85

The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood. Surg Gynecol Obstet (1973) 3.84

Effects of insulin, glucagon, and insuling/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs. Lancet (1976) 3.74

Immunosuppressive effect of FK-506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A. Transplant Proc (1987) 3.73

Hepatic trisegmentectomy and other liver resections. Surg Gynecol Obstet (1975) 3.66

Right trisegmentectomy for hepatic neoplasms. Surg Gynecol Obstet (1980) 3.64

Systemic chimerism in human female recipients of male livers. Lancet (1992) 3.63

Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation (1995) 3.63

Hepatic Retransplantation. Transplant Proc (1985) 3.62

Transplantation of multiple abdominal viscera. JAMA (1989) 3.59

Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg (1991) 3.57

Canine kidney transplantation with FK-506 alone or in combination with cyclosporine and steroids. Transplant Proc (1987) 3.55

Canine liver transplantation under Nva2-cyclosporine versus cyclosporine. Transplantation (1986) 3.54

Combination donor hepatectomy and nephrectomy and early functional results of allografts. Surg Gynecol Obstet (1982) 3.49

Long-term survival after renal transplantation in humans: (with special reference to histocompatibility matching, thymectomy, homograft glomerulonephritis, heterologous ALG , AND RECIPIENT MALIGNANCY). Ann Surg (1970) 3.48


Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant (2014) 3.43

Selected topics on FK 506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics. Transplant Proc (1991) 3.40

Nephrotoxicity of cyclosporin A in liver and kidney transplant patients. Lancet (1981) 3.38

The relation of preoperative coagulation findings to diagnosis, blood usage, and survival in adult liver transplantation. Transplantation (1985) 3.38

Chimerism after liver transplantation for type IV glycogen storage disease and type 1 Gaucher's disease. N Engl J Med (1993) 3.36

Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology (1991) 3.34

Kidney transplantation under FK 506 immunosuppression. Transplant Proc (1991) 3.31

Early trials with FK 506 as primary treatment in liver transplantation. Transplant Proc (1990) 3.29

Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant (2010) 3.29